All In Biotech

Drug Trial Radar · NCT01607957

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

800

Actual

Start

Jun 17, 2012

Primary completion

Jan 31, 2014

Study completion May 23, 2016

Sponsor

Lead sponsor
Taiho Oncology, Inc.Industry
Sponsor type
Industry
First posted
May 30, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of TAS-102 versus placebo in patients with refractory metastatic colorectal cancer.

Conditions

  • Colorectal Cancer

Interventions

  • TAS-102Drug

    35 mg/m2/dose, orally, twice daily on days 1-5 and 8-12 of each 28-day cycle. Number of cycles: until at least one of the discontinuation criteria are met.

  • PlaceboDrug

    Placebo tablets, orally, twice daily on days 1-5 and 8-12 of each 28-day cycle. Number of cycles: until at least one of the discontinuation criteria are met.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: Every 8 weeks, up to 12 months after the last participant was randomized or until the target number of events (deaths) was met, whichever was later. (Overall survival data was collected till 24 Jan 2014 which was date of observation of the 571st death)

Locations

115 sites in 13 countries. Site status is shown where the registry gives one.

  • Arizona Center for Cancer Care

    Glendale, Arizona

  • California Cancer Associates for Research and Excellence

    Fresno, California

  • Ronald H. Yanagihara, MD

    Gilroy, California

  • LAC and USC Medical Center

    Los Angeles, California

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California

  • Pacific Hematology Oncology Associates

    San Francisco, California

  • San Jose Medical Group

    San Jose, California

  • Coastal Integrative Cancer Care

    San Luis Obispo, California

  • Yale Cancer Center

    New Haven, Connecticut

  • MD Anderson Cancer Center Orlando

    Orlando, Florida

  • Illinois Cancer Care, P.C.

    Peoria, Illinois

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana

  • Mary Bird Perkins Cancer Center

    Baton Rouge, Louisiana

  • Ochsner Clinic Fndtn

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • St. Joseph Mercy Hospital

    Ann Arbor, Michigan

  • Jefferson City Medical Group

    Jefferson City, Missouri

  • Saint Luke's Cancer Institute

    Kansas City, Missouri

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • Gabrail Cancer Center

    Canton, Ohio

  • Hickman Cancer Center at Flower Hospital

    Sylvania, Ohio

  • Hematology/Oncology Associates of Fredericksburg

    Fredericksburg, Virginia

  • Royal North Shore Hospital

    Sydney, New South Wales, Australia

  • The Queen Elisabeth Hospital

    Woodville South, South Australia, Australia

  • Austin Hospital

    Heidelberg, Victoria, Australia

  • The Royal Melbourne Hospital

    Parkville, Victoria, Australia

  • Sir Charles Gairdner Hospital

    Perth, Western Australia, Australia

  • Krankenhaus der Barmherzigen Schwestern Linz

    Linz, Austria

  • Universitaet Wien

    Vienna, Austria

  • Universitaetsklinik fur Innere Medizin

    Vienna, Austria

  • Wilhelminenspital Wien

    Vienna, Austria

  • Klinikum Wels-Grieskirchen GmbH

    Wels, Austria

  • Cliniques Universitaires UCL St. Luc

    Brussels, Belgium

  • Erasme University Hospital-ULB-Brussels

    Brussels, Belgium

  • Grand Hospital de Charleroi

    Charleroi, Belgium

  • Antwerp University Hospital

    Edegem, Belgium

  • University Hospital Gent

    Edegem, Belgium

  • University Hospital Gent

    Ghent, Belgium

  • Leuven University Hospital - Campus Gasthuiseberg

    Leuven, Belgium

Showing 40 of 115 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.